Study sheds new light on p53 tumor suppressor gene’s role in ulcerative colitis

Researchers in the lab of Michael Sigal at the Max Delbrück Center and Charité – Universitätsmedizin Berlin have elucidated the role of the p53 gene in ulcerative colitis.

Researchers seek answers to racial disparities for prostate and breast cancer among people of African ancestry

For almost 44 years, Willie Bell never missed his appointment to check for prostate cancer. But then the pandemic hit. The doctor’s office was closed.

August 1, 2023

Beam doses first patient with base-edited cell therapy

Beam Therapeutics announced Tuesday that it dosed its first patient with its base-edited CAR-T treatment last month. BEAM-201 is an “off-the-shelf” cell therapy for patients

September 6, 2023

Which pharmacotherapies are associated with improved outcomes for people with alcohol use disorder?

Researchers assessed the efficacy and compared the relative effectiveness of various pharmacological treatments for alcohol use disorder.

November 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.